Seud is proud to announce the launching of the JEUD, its official journal in collaboration with ELSEVIER! A new journal for SEUD Members only.

Join our society

Become part of a global scientific society advancing the diagnosis and treatment of Endometriosis and related Uterine Disorders around the world.

previous arrowprevious arrow
next arrownext arrow

SEUD Objectives:

The Society of Endometriosis and Uterine Disorders (SEUD)’s main objective is to provide an international scientific platform to help and train every physician in the field of endometriosis and uterine disorders get a better management of benign gynecological diseases and related uterine dysfunctions. Beyond the surgical techniques and the scientific innovations, SEUD’s main focus is and will always be the patient.

Raise Awareness

SEUD’s objective is to focus attention on a group of diseases that negatively affect womens’ health and fertility, including endometriosis, adenomyosis, uterine fibroids, polyps, heavy menstrual bleeding and uterine malformations.

Improve Lives

SEUD aims to improve disease management and reduce the impact on women’s lives through focused debate on disease awareness, pathogenesis, risk factors, diagnosis and medical/surgical treatments.

Share Knowledge

SEUD also represents an international forum to promote education and training for a new generation of young experts with new perspectives based on translational research experience.

What’s going on?

Apply for SEUD Research Grant

The SEUD Research Grant Program is a new initiative to stimulate research from young investigators.
(Submit your project three months before the SEUD annual Congress)

SEUD & Friends

A series of 10 short and dynamic interviews featuring renowned experts.

A new way to share invaluable insights, tips & tricks.

Get Involved

If you’re a doctor or healthcare professional, you can join us to get access to our exclusive resources and to meet the best minds in the area of Endometriosis.

Our corporate partners
Note: Carousel will only load on frontend.